The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBC12.L Regulatory News (BC12)

  • There is currently no data for BC12

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close announcement - Interim Report 2016

8 Nov 2016 16:00

RNS Number : 6606O
Better Capital PCC Limited
08 November 2016
 

 

 

BETTER CAPITAL PCC LIMITED

(the "Company")

 

8 November 2016

 

Pre close announcement - Interim Report 2016

 

The Board of Better Capital PCC Limited (the "Company") has received an update from the General Partner of the Better Capital Funds ahead of the release of the Interim Report to 30 September 2016.

 

2009 Cell

 

Gardner continues to perform to expectation. The sale process has commenced and is receiving strong global interest. It is anticipated that negotiations will be concluded with a selected bidder pre-Christmas. 

 

The progress of m-Hance has been slower than planned primarily due to lower monthly sales than budgeted. However, there have been new sales wins and the pipeline is stronger going into Q4 FY16, both in the Microsoft GP and the HighCloud (NetSuite) services.

 

Omnico closed its financial year ended 30 September 2016 with positive EBITDA, a considerable improvement on the loss reported for the prior year. This performance demonstrates a turnaround for the business which has successfully moved away from the legacy custom software development and hardware manufacture to focus on core product development and delivery for Food, Beverage and Retail customers. Opportunities in Hospitality, Entertainment and Retail are looking increasingly positive, particularly in theme parks in the US, Middle East and Asia due to market expansion.

 

SPOT, which is a minority interest in Fund I, is discussed further below.

 

The Board of the Company has been advised by Fund I GP that the 2009 Cell is anticipated to report a modest uplift to NAV as at 30 September 2016 which is largely driven by the performance in Gardner.

 

2012 Cell

 

Everest is expected to close FY16 with positive EBITDA better than prior year albeit, significantly below expectations and potential, and with a much improved order pipeline going into FY17. This follows on from a series of cost reduction and revenue enhancing initiatives launched during the year. Net cash is improved.

 

Recent financial performance in Jaeger has been disappointing. Having enjoyed a strong start to its FY17 financial year through its Spring/ Summer 2016 collection with LFLs, full price sell through and EBITDA ahead of budget, the end of season sale proved very competitive with deeper markdowns and a longer sales period. The start of Autumn/ Winter 2016 sales have been slow with the warm weather affecting sales of outerwear. The consequent increase in competitive promotional activity means that trading continues to be challenging. The business received £3.0 million of new funding from Fund II in September 2016.

 

SPOT is trading profitably with good cash generation, ahead of prior year but below budgeted levels in a fiercely competitive environment. Daily sales were impacted over the summer period following Brexit with margins under pressure mainly due to FX price increases. Cash flow has improved.

 

iNTERTAIN has traded well ahead of prior year although marginally behind expectations. The business performed strongly throughout the Euro 2016 tournament but the prolonged period of hotter than usual weather in July to September was unhelpful to a business with limited outdoor areas. The business has added one new venue since the Annual Report.

 

CAV continues its trend of steady improvement on an operational and financial basis. Considerable progress in areas such as machine maintenance and health and safety have helped improve both product quality and the working environment. Customer arrears are significantly and consistently reducing. The warranty claim process is continuing. Significant restructuring and customer renegotiations continue.

 

Since the Annual Results, Fund II acquired a further 23.7 million Better Capital 2012 Shares ("2012 Shares") with an average gross price of 31.96 pence per share. At 30 September 2016, Fund II held 57.1 million shares (16.47 per cent. of the 2012 Cell share capital). The 2012 Shares are valued based on their quoted closing price at that date of 33.00 pence. Subject to shareholder consents, it is the Company's current intention to acquire up to 50 per cent. of Fund II's holding of the 2012 Shares by way of an off-market transaction and to cancel these on acquisition. Further communication on the matter will be made in due course. 

 

The Fund II GP has advised the Board that the recent underperformance in Everest, Jaeger and SPOT against their respective current year budgets is expected to impact the 2012 Cell NAV as at 30 September 2016 with a current expectation of a decline in the region of 14 per cent. 

 

Further details will be provided in the Interim Results expected to be released on 30 November 2016.

 

 

Enquiries:

 

Better Capital PCC Limited +44 (0) 1481 716 000

Laurence McNairn (Administrator and Company Secretary)

 

Better Capital LLP +44 (0) 20 7440 0840

Bonnie Kraus (Investor Relations)

 

Powerscourt +44 (0) 20 7250 1446

Justin Griffiths

 

Numis Securities +44 (0) 20 7260 1426

Nathan Brown

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSELALTIIR
Date   Source Headline
11th Dec 20145:14 pmRNSHolding(s) in Company
8th Dec 20144:36 pmRNSDirector/PDMR Shareholding
4th Dec 20142:27 pmRNSDirector/PDMR Shareholding
3rd Dec 20147:00 amRNSDirector/PDMR Shareholding
28th Nov 20144:40 pmRNSDirector/PDMR Shareholding
28th Nov 201412:06 pmRNSInterim Results Update
10th Nov 20147:00 amRNSAcquisition
16th Oct 20145:00 pmRNSDirector Declaration
23rd Sep 201411:00 amRNSFurther Funding
19th Sep 201411:57 amRNSFurther Funding
8th Sep 20144:25 pmRNSResult of AGM
1st Sep 20147:00 amRNSDistribution of Capital
1st Sep 20147:00 amRNSFurther Funding
15th Aug 201410:11 amRNSNotice of AGM
12th Aug 20147:00 amRNSInterim Management Statement
30th Jul 20147:00 amRNSFinal Results Update
29th Jul 20147:00 amRNSNotice of Transaction
25th Jul 20147:00 amRNSAcquisition of OfficeTeam
30th Jun 201412:14 pmRNSHolding(s) in Company
24th Jun 20143:44 pmRNSTimetable for Final Results
21st May 20141:30 pmRNSFurther Funding
27th Mar 20141:00 pmRNSFurther Investment into Jaeger
17th Feb 20147:00 amRNSInterim Management Statement
4th Feb 20147:00 amRNSTrading Statement
21st Jan 20143:27 pmRNSNon-Mainstream Pooled Investments
25th Nov 20137:00 amRNSInterim Results Update
21st Aug 20132:25 pmRNSHolding(s) in Company
21st Aug 20131:08 pmRNSHolding(s) in Company
20th Aug 201310:04 amRNSHolding(s) in Company
16th Aug 20133:51 pmRNSHolding(s) in Company
13th Aug 201312:37 pmRNSDirector/PDMR Shareholding
13th Aug 201312:30 pmRNSResult of EGM & Result of Placing and Open Offer
6th Aug 201312:47 pmRNSInterim Management Statement
1st Aug 20133:00 pmRNSAmendment to Official List
31st Jul 20133:00 pmRNSResult of AGM
30th Jul 20137:00 amRNSPublication of Prospectus
29th Jul 20137:00 amRNSFirm Placing & Placing & Open Offer of 2012 Shares
11th Jul 201312:00 pmRNSNotice of AGM
28th Jun 20137:00 amRNSFinal Results Update
25th Jun 20138:51 amRNSUpdate on 2012 Cell
10th Jun 20137:00 amRNSNAV Update
2nd May 20134:35 pmRNSFirst Order Red Acquisition
29th Apr 201311:40 amRNSCity Link Acquisition
22nd Mar 20137:00 amRNSDistribution of Capital
1st Mar 20132:00 pmRNSDisposal of Secured Debt
28th Feb 20134:17 pmRNSResult of EGM
15th Feb 20137:00 amRNSInterim Management Statement
11th Feb 20135:00 pmRNSFurther re Notice of EGM & Publication of Circular
11th Feb 20137:00 amRNSNotice of EGMs and Publication of Circular
9th Jan 201310:00 amRNSJoint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.